Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	56.51B
Revenue (ttm)	13.11B
Net Income (ttm)	1.38B
Shares Out	1.77B
EPS (ttm)	0.78
PE Ratio	42.95
Forward PE	28.94
Dividend	0.20 (0.60%)
Ex-Dividend Date	Jul 4, 2025

Volume	31,538,408
Average Volume	59,456,317
Open	35.71
Previous Close	34.60
Day's Range	33.30 - 35.71
52-Week Range	20.47 - 37.63
Beta	0.92
RSI	53.41
Earnings Date	Oct 27, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.